カリフォルニア州における鎌状赤血球症の臨床試験
カリフォルニア州内の拠点で、鎌状赤血球症に関する18件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Exercise in Child Health
- University of California, Irvine, Irvine
被験者募集中健康なボランティア歓迎
10歳〜17歳 · 全性別 · 2026/10/02更新 · NCT05359991A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Ctr for Inherited Blood Disorders, Orange
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Children's Hospital Los Angeles - Endocrinology, Los Angeles
- UCSF Oakland Benioff ChildHosp, Oakland
被験者募集中第3相
2歳以上 · 全性別 · 2026/09/18更新 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Hospital Los Angeles - Endocrinology, Los Angeles
- Valley Children's Hospital, Madera
- Stanford University_Palo Alto, Palo Alto
- 他1件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/17更新 · NCT06612268Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
- Harbor UCLA Medical Center, Torrance
被験者募集中第2相
5歳〜20歳 · 全性別 · 2026/09/02更新 · NCT07369024A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- University of California San Diego - La Jolla, La Jolla
- UCSF Benioff Children's Hospital Oakland, Oakland
被験者募集中第1/2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/18更新 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Orthopaedic Institute for Children HTC, Los Angeles
- Childrens Hospital Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital Oakland, Oakland
- 他5件
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/17更新 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Univ. of California, San Francisco Health Care, Oakland
- University of California Irvine, Orange
被験者募集中第2相
12歳以上 · 全性別 · 2026/08/14更新 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- University of California Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- University of California San Francisco- Site Number : 8400040, Fresno
被験者募集中第3相
10歳〜65歳 · 全性別 · 2026/07/29更新 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of California Los Angeles, Los Angeles
被験者募集中第2相
6 Months – 21 Years · 全性別 · 2026/07/27更新 · NCT02675959Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
- UC Davis Comprehensive Cancer Center, Sacramento
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/07/16更新 · NCT06016634Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Children's Hospital Los Angeles, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
被験者募集中第1/2相
12歳〜50歳 · 全性別 · 2026/07/02更新 · NCT04819841Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
- City of Hope Medical Center, Duarte
被験者募集中第1相
1歳〜30歳 · 全性別 · 2026/05/12更新 · NCT03279094Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
- University of California, Los Angeles, Los Angeles
- UCSF Benioff Children's Hospital, Oakland
被験者募集中第1/2相
12歳〜35歳 · 全性別 · 2026/04/16更新 · NCT04774536Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- UCSF Benioff Children's Hospital Oakland, Oakland
被験者募集中第2相
15歳〜40歳 · 全性別 · 2026/03/13更新 · NCT06260891Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- UCLA Mattel Children's Hospital Ronald Reagan Hospital, Los Angeles
被験者募集中
16歳〜30歳 · 全性別 · 2026/01/07更新 · NCT06374238Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of California, San Francisco (UCSF), Oakland
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/22更新 · NCT06385886ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。